Talphera, Inc. (TLPH) 2017年年度报告「NASDAQ」.pdf

《Talphera, Inc. (TLPH) 2017年年度报告「NASDAQ」.pdf》由会员分享，可在线阅读，更多相关《Talphera, Inc. (TLPH) 2017年年度报告「NASDAQ」.pdf（125页珍藏版）》请在三个皮匠报告上搜索。

1、 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,DC 20549FORM 10-KANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31,2017 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For th

2、e transition period from to Commission File Number:001-35068ACELRX PHARMACEUTICALS,INC.(Exact name of registrant as specified in its charter)Delaware41-2193603(State or other jurisdiction ofincorporation or organization)(IRS EmployerIdentification No.)351 Galveston DriveRedwood City,CA 94063(650)216

3、-3500(Address,including zip code,and telephone number,including area code,of registrants principal executive offices)Securities registered pursuant to Section 12(b)of the Act:Title of Each ClassName of Each Exchange on Which RegisteredCommon Stock,$0.001 par valueThe NASDAQ Stock Market LLC Securiti

4、es registered pursuant to Section 12(g)of the Act:NoneIndicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Ac

5、t.Yes No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject to s

6、uchfiling requirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site,if any,every Interactive Data Filerequired to be submitted and posted pursuant to Rule 405 of Regulation S-T(-232.405 of this chapter)dur